Generated by AI
Summary of Nov 9's posts. Generated by AI.
Summary of Sep 2's posts. Generated by AI.
Summary of Aug 8's posts. Generated by AI.
Summary of Nov 9's posts. Generated by AI.
Investors talking about IONS also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.
Ionis Pharmaceuticals, Inc. is a commercial-stage biotechnology company focused on discovering and developing RNA-targeted medicines. Using its proprietary antisense technology, Ionis creates therapies designed to modulate gene expression and address serious diseases, particularly in neurology and cardiometabolic care, as well as other high-need therapeutic areas. The company currently markets several medicines for conditions such as spinal muscular atrophy, hereditary amyloidosis, amyotrophic lateral sclerosis, and certain rare cardiovascular and metabolic disorders. Ionis also maintains an active pipeline of investigational programs and collaborates with pharmaceutical partners to expand the reach of its platform. Headquartered in Carlsbad, California, Ionis Pharmaceuticals plays a significant role in the biotechnology market as a leading developer of RNA-based therapeutics.
Website2855 Gazelle Court
Carlsbad, CA, 92010
United States
The latest articles about IONS.